C-Trials Global Inc. company information, Employees & Contact Information

Global AI In Clinical Trials: Market Trends & Current Partnerships Clinical Leader

PACE-C Trial: Comparing SBRT and MHRT in Prostate Cancer Oncodaily

BOND-003 Cohort C Trial Results for Cretostimogene Grenadenorepvec in BCG-Unresponsive Bladder Cancer - Mark Tyson UroToday

Lantern Pharma Announces Completion of Type C Meeting with FDA, Providing Clarity on Regulatory Pathway for Pediatric CNS Cancer Trial Business Wire

Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial The Lancet

Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics Business Wire

Preliminary Results from the POTEN-C Trial – ESTRO Oncodaily

Blinded, randomized trial of sonographer versus AI cardiac function assessment Nature

AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial Clinical Trials Arena

Hepatitis C Treatment Clinical Trials: Where to Find Healthline

Clinical trials of UroActive System receive support from Series C Financing Urology Times

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer ScienceDirect.com

Early administration of vitamin C in patients with sepsis or septic shock in emergency departments: a multicenter, double-blind, randomized controlled trial: the C-EASIE trial BioMed Central

11 clinical trials that will shape medicine in 2023 Nature

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials Business Wire

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial The Lancet

The latest results from the PACE-C trial presented at ESTRO24 Oncodaily

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma | British Journal of Cancer Nature

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial Nature

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome Nature

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials The Lancet

A new clinical trial to test high-dose vitamin C in patients with COVID-19 BioMed Central

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Nature

IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal Melanoma PR Newswire

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results Nature

Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria Dermatology Times

A meta-analysis of randomized clinical trials on the impact of oral vitamin C supplementation on first-year outcomes in orthopedic patients Nature

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial ScienceDirect.com

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials The Lancet

Effectiveness of Oral Vancomycin in Preventing C difficile Remains Uncertain After Trial Contagion Live

Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials Business Wire

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials - eClinicalMedicine The Lancet

Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C) ScienceDirect.com

Universal Hepatitis C Screening in EDs Detects More Infections, but Gaps in Care Remain Contagion Live

Evaluating the effects of chlorhexidine and vitamin c mouthwash on oral health in non-surgical periodontal therapy: a randomized controlled clinical trial Nature

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C) BMC Cancer

C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 ‘LIVE-AIR’ trial thorax.bmj.com

Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials The BMJ

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial The BMJ

James Lind: The man who helped to cure scurvy with lemons BBC

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial The Lancet

Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial The BMJ

Effect of vitamin C on common cold: randomized controlled trial | European Journal of Clinical Nutrition Nature